CAS 127-07-1
:Hydroxyurea
Description:
Hydroxyurea, with the CAS number 127-07-1, is a chemical compound that serves as an antineoplastic agent, primarily used in the treatment of certain cancers, such as chronic myeloid leukemia and head and neck cancers, as well as in managing sickle cell disease. It is a white, crystalline solid that is soluble in water and exhibits a molecular formula of C₄H₈N₂O₂. Hydroxyurea functions as a ribonucleotide reductase inhibitor, which disrupts DNA synthesis by preventing the conversion of ribonucleotides to deoxyribonucleotides, thereby inhibiting cell proliferation. The compound is also known for its ability to increase fetal hemoglobin levels in patients with sickle cell disease, which can reduce the frequency of painful crises. Hydroxyurea is typically administered orally and may have side effects, including myelosuppression, gastrointestinal disturbances, and potential teratogenic effects, necessitating careful monitoring during treatment. Its mechanism of action and therapeutic applications make it a significant agent in oncology and hematology.
Formula:CH4N2O2
InChI:InChI=1/CH4N2O2/c2-1(4)3-5/h3H2,(H2,2,4)
InChI key:InChIKey=VSNHCAURESNICA-UHFFFAOYSA-N
SMILES:C(NO)(N)=O
Synonyms:- 1-Hydroxyurea
- Amino(Oxido-Λ5-Azanyl)Methanone
- Biosupressin
- Carbamohydroxamic acid
- Carbamohydroximic acid
- Carbamoyl oxime
- Carbamyl hydroxamate
- Cytodrox
- Droxia
- HU
- Hidrix
- Hidroxicarbamida
- Hydrea
- Hydreia
- Hydrixycarbamide
- Hydroxy Urea (D4)
- Hydroxy urea
- Hydroxycarbamid
- Hydroxycarbamide
- Hydroxycarbamine
- Hydroxylamine, N-(aminocarbonyl)-
- Hydroxylurea
- Hydura
- Hydurea
- Litaler
- Litalir
- Mylocel
- N-(aminocarbonyl)hydroxylamine
- N-Carbamoylhydroxylamine
- N-Hydroxyharnstoff
- N-Hydroxyurea
- Nci C04831
- Nsc 32065
- Onco-carbide
- Oxyrea
- Oxyurea
- Siklos
- Sk 22591
- Sq 1089
- Urea, N-hydroxy-
- Urea, hydroxy-
- Wr 83799
- Xromi
- hydroxyharnstoff
- carbamylhydroxamate
- Carbamoylhydroxylamine
- carbamohydroxyamicacid
- carbamohydroxamicacid
- hydroxy-ure
- HYDROXYUREA
- carbamoyloxime
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 16 products.
Hydroxyurea
CAS:Formula:CH4N2O2Purity:>97.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:76.06Hydroxyurea, 98%
CAS:<p>Hydroxyurea is used as an inhibitor of DNA synthesis and an anti-cancer drug. It is used as a precursor to prepare 1-hydroxy-5,6-dimethyl-1H-pyrimidine-2,4-dione via reaction with 2-methyl-3-oxo-butyric acid ethyl ester. It is used in the treatment of melanoma, resistant chronic myelocytic leukemia </p>Formula:CH4N2O2Purity:98%Color and Shape:White to cream or yellow, Crystals or powder or crystalline powderMolecular weight:76.06HYDROXYCARBAMIDE CRS
CAS:<p>HYDROXYCARBAMIDE CRS</p>Formula:CH4N2O2Color and Shape:Crystalline Powder. White. Powder.Molecular weight:76.0547Hydroxycarbamide
CAS:HydroxycarbamideFormula:CH4N2O2Purity:99.6%Color and Shape:Off-WhiteMolecular weight:76.02728Hydroxyurea
CAS:<p>Non-aromatic organic derivatives of hydrazine or of hydroxylamine for use as drugs</p>Formula:CH4N2O2Color and Shape:White Off-White PowderMolecular weight:76.06 g/molHydroxyurea
CAS:<p>Hydroxyurea (Hydroxycarbamide), an antineoplastic agent, inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.</p>Formula:CH4N2O2Purity:99.85% - 99.92%Color and Shape:SolidMolecular weight:76.05Hydroxyurea
CAS:Formula:CH4N2O2Purity:98.0 - 102.0 % (anhydrous basis)Color and Shape:White to off-white powderMolecular weight:76.06Hydroxyurea
CAS:<p>Hydroxyurea</p>Formula:CH4N2O2Purity:98%Color and Shape: white solidMolecular weight:76.05g/molHydroxy Urea
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.<br>References Ratcliffe, W., et al.: Lancet, 339, 164 (1992), Roodman, G., et al.: Cancer, 80, 1557 (1997), Horwitz, M., et al.: J. Clin. Endocrinol. Metab., 2003, 88, 1603 (2003),<br></p>Formula:CH4N2O2Color and Shape:White SolidMolecular weight:76.05Hydroxyurea
CAS:<p>Hydroxyurea is a prodrug that is activated by the enzyme Jak2, which is found in the mitochondria of cells. Hydroxyurea is used to treat various types of cancer and other diseases, such as sickle cell anemia. It has been shown to be effective in inhibiting the growth of squamous cell carcinomas and myeloid leukemia cells. Hydroxyurea has also been shown to have synergistic effects when combined with other pharmacological agents, such as hydroxycarbamide and cytosine arabinoside. Hydroxyurea inhibits the production of energy in the form of ATP, which leads to death by apoptosis or necrosis. This drug also has inhibitory properties against bacterial infections, especially those caused by Mycobacterium tuberculosis and Mycobacterium avium complex.</p>Formula:CH4N2O2Purity:Min. 97.5 Area-%Color and Shape:White Off-White PowderMolecular weight:76.06 g/molHydroxyurea
CAS:Formula:CH4N2O2Purity:98%Color and Shape:Solid, White crystalline powderMolecular weight:76.055














